Literature DB >> 2666450

Pharmacokinetics of capacity-limited systems.

W J Jusko1.   

Abstract

Nonlinearities are commonplace in pharmacokinetics and most frequently occur because of a limited concentration of biological material available for interaction with relatively high concentrations of drugs. The Michaelis-Menten-type function can be applied to metabolism, transport, and binding phenomena that display capacity-limitation. Nonlinear systems can be handled with differential equations (directly or converted to linear form), integrated equations (in non-closed form) or with relatively new area/moment or MRT relationships. Drug disposition studies should include several dose levels and recommendations are provided for detecting the presence of one or more nonlinear absorption or disposition processes in typical experimental data.

Mesh:

Substances:

Year:  1989        PMID: 2666450     DOI: 10.1002/j.1552-4604.1989.tb03369.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  7 in total

1.  Multiplicative dependence of the first order rate constant and its impact on clinical pharmacokinetics and bioequivalence.

Authors:  Pietro Fagiolino
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2004 Jan-Mar       Impact factor: 2.441

2.  Quantitative modeling of the dynamics and intracellular trafficking of far-red light-activatable prodrugs: implications in stimuli-responsive drug delivery system.

Authors:  Mengjie Li; Pritam Thapa; Pallavi Rajaputra; Moses Bio; Cody J Peer; William D Figg; Youngjae You; Sukyung Woo
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-09-14       Impact factor: 2.745

3.  Piperacillin and tazobactam exhibit linear pharmacokinetics after multiple standard clinical doses.

Authors:  B Auclair; M P Ducharme
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

4.  Liposomal methylprednisolone in rats: dose-proportionality and chronic-dose pharmacokinetics/pharmacodynamics.

Authors:  E V Mishina; W J Jusko
Journal:  Pharm Res       Date:  1996-01       Impact factor: 4.200

5.  Barriers to Building More Effective Treatments: Negative Interactions Amongst Smoking Intervention Components.

Authors:  Timothy B Baker; Daniel M Bolt; Stevens S Smith
Journal:  Clin Psychol Sci       Date:  2021-04-26

6.  Selection between Michaelis-Menten and target-mediated drug disposition pharmacokinetic models.

Authors:  Xiaoyu Yan; Donald E Mager; Wojciech Krzyzanski
Journal:  J Pharmacokinet Pharmacodyn       Date:  2009-12-10       Impact factor: 2.745

7.  Pharmacokinetic model of target-mediated disposition of thrombopoietin.

Authors:  Feng Jin; Wojciech Krzyzanski
Journal:  AAPS PharmSci       Date:  2004-03-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.